Adult Cancer Pain

Restricted access
  • 1.

    Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl 1986;3(Supp 1):226.

    • Search Google Scholar
    • Export Citation
  • 2.

    Cohen MZ, Easley MK, Ellis C et al. . Cancer pain management and the JCAHO's pain standards: an institutional challenge. J Pain Symptom Manage 2003;25:519527.

    • Search Google Scholar
    • Export Citation
  • 3.

    Goudas LC, Bloch R, Gialeli-Goudas M et al. . The epidemiology of cancer pain. Cancer Invest 2005;23:182190.

  • 4.

    Svendsen KB, Andersen S, Arnason S et al. . Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 2005;9:195206.

    • Search Google Scholar
    • Export Citation
  • 5.

    Cleeland CS, Gonin R, Hatfield AK et al. . Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592596.

  • 6.

    Martin LA, Hagen NA. Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. J Pain Symptom Manage 1997;14:99117.

    • Search Google Scholar
    • Export Citation
  • 7.

    Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997;69:118.

  • 8.

    Stjernsward J. WHO cancer pain relief programme. Cancer Surv 1988;7:195208.

  • 9.

    Stjernsward J, Colleau SM, Ventafridda V. The World Health Organization Cancer Pain and Palliative Care Program. Past, present, and future. J Pain Symptom Manage 1996;12:6572.

    • Search Google Scholar
    • Export Citation
  • 10.

    Caraceni A, Weinstein SM. Classification of cancer pain syndromes. Oncology (Williston Park) 2001;15:16271640.

  • 11.

    Hewitt DJ. The management of pain in the oncology patient. Obstet Gynecol Clin North Am 2001;28:819846.

  • 12.

    Portenoy RK. Cancer pain. Epidemiology and syndromes. Cancer 1989;63:22982307.

  • 13.

    Hicks CL, von Baeyer CL, Spafford PA et al. . The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain 2001;93:173183.

    • Search Google Scholar
    • Export Citation
  • 14.

    Serlin RC, Mendoza TR, Nakamura Y et al. . When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277284.

    • Search Google Scholar
    • Export Citation
  • 15.

    Soetenga D, Frank J, Pellino TA. Assessment of the validity and reliability of the University of Wisconsin Children's Hospital Pain scale for Preverbal and Nonverbal Children. Pediatr Nurs 1999;25:670676.

    • Search Google Scholar
    • Export Citation
  • 16.

    Al-Atiyyat HN. Cultural diversity and cancer pain. J Hosp Palliat Nurs 2009;11:154164.

  • 17.

    Ezenwa MO, Ameringer S, Ward SE, Serlin RC. Racial and ethnic disparities in pain management in the United States. J Nurs Scholarsh 2006;38:225233.

    • Search Google Scholar
    • Export Citation
  • 18.

    American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 5th ed. Glenview, IL: American Pain Society; 2003.

    • Search Google Scholar
    • Export Citation
  • 19.

    Mercadante SL, Berchovich M, Casuccio A et al. . A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hosp Palliat Care 2007;24:1319.

    • Search Google Scholar
    • Export Citation
  • 20.

    Klepstad P, Kaasa S, Borchgrevink PC. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol 2000;55:713719.

    • Search Google Scholar
    • Export Citation
  • 21.

    Klepstad P, Kaasa S, Skauge M, Borchgrevink PC. Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation. Acta Anaesthesiol Scand 2000;44:656664.

    • Search Google Scholar
    • Export Citation
  • 22.

    Cherny NI. The pharmacologic management of cancer pain. Oncology (Williston Park) 2004;18:14991515.

  • 23.

    Hanks GW, Conno F, Cherny N et al. . Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001;84:587593.

  • 24.

    Kornick CA, Santiago-Palma J, Khojainova N et al. L. A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl. Cancer 2001;92:30563061.

    • Search Google Scholar
    • Export Citation
  • 25.

    Tiseo PJ, Thaler HT, Lapin J et al. . Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients. Pain 1995;61:4754.

    • Search Google Scholar
    • Export Citation
  • 26.

    Portenoy RK, Foley KM, Stulman J et al. . Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure. Pain 1991;47:1319.

    • Search Google Scholar
    • Export Citation
  • 27.

    Davis MP, Homsi J. The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine. Support Care Cancer 2001;9:442451.

  • 28.

    Bruera E, Kim HN. Cancer pain. JAMA 2003;290:24762479.

  • 29.

    Barkin RL, Barkin SJ, Barkin DS. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity. Am J Ther 2006;13:534542.

    • Search Google Scholar
    • Export Citation
  • 30.

    Goldstein DJ, Turk DC. Dextropropoxyphene: safety and efficacy in older patients. Drugs Aging 2005;22:419432.

  • 31.

    Aubert R, Stanek EJ, Yao J et al. . Risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors [abstract]. J Clin Oncol 2009;27(Suppl 1):Abstract CRA508.

    • Search Google Scholar
    • Export Citation
  • 32.

    Dezentje V, Van Blijderveen NJ, Gelderblom H et al. . Concomitant CYP2D6 inhibitor use and tamoxifen adherence in early-stage breast cancer: a pharmacoepidemiologic study [abstract]. J Clin Oncol 2009;27(Suppl 1):Abstract CRA509.

    • Search Google Scholar
    • Export Citation
  • 33.

    Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999;353:16951700.

  • 34.

    Stevens RA, Ghazi SM. Routes of opioid analgesic therapy in the management of cancer pain. Cancer Control 2000;7:132141.

  • 35.

    Harris JT, Suresh Kumar K, Rajagopal MR. Intravenous morphine for rapid control of severe cancer pain. Palliat Med 2003;17:248256.

  • 36.

    McNicol E, Horowicz-Mehler N, Fisk RA et al. . Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4:231256.

    • Search Google Scholar
    • Export Citation
  • 37.

    Mercadante SComments on Wang et al. ., PAIN, 67 (1996) 407-416. Pain 1998;74:106–107.

  • 38.

    Mercadante S. Pathophysiology and treatment of opioid-related myoclonus in cancer patients. Pain 1998;74:59.

  • 39.

    Wilson RK, Weissman DE. Neuroexcitatory effects of opioids: patient assessment #57. J Palliat Med 2004;7:579.

  • 40.

    Moryl N, Carver A, Foley KM. Pain and palliation. In: Holland JF, Frei E, eds. Cancer Medicine. Vol. I7. Hamilton, ON: BC Decker Inc; 2006:11131124.

    • Search Google Scholar
    • Export Citation
  • 41.

    Moryl N, Obbens EA, Ozigbo OH, Kris MG. Analgesic effect of gefitinib in the treatment of non-small cell lung cancer. J Support Oncol 2006;4:111.

  • 42.

    Boettger S, Breitbart W. Atypical antipsychotics in the management of delirium: a review of the empirical literature. Palliat Support Care 2005;3:227237.

    • Search Google Scholar
    • Export Citation
  • 43.

    Breitbart W, Marotta R, Platt MM et al. . A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:231237.

    • Search Google Scholar
    • Export Citation
  • 44.

    Bruera E, Belzile M, Neumann C et al. . A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 2000;19:427435.

    • Search Google Scholar
    • Export Citation
  • 45.

    Challoner KR, McCarron MM, Newton EJ. Pentazocine (Talwin) intoxication: report of 57 cases. J Emerg Med 1990;8:6774.

  • 46.

    Katcher J, Walsh D. Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride. J Pain Symptom Manage 1999;17:7072.

  • 47.

    Marinella MA. Acute colonic pseudo-obstruction complicated by cecal perforation in a patient with Parkinson's disease. South Med J 1997;90:10231026.

    • Search Google Scholar
    • Export Citation
  • 48.

    Reissig JE, Rybarczyk AM. Pharmacologic treatment of opioid-induced sedation in chronic pain. Ann Pharmacother 2005;39:727731.

  • 49.

    Tarcatu D, Tamasdan C, Moryl N, Obbens E. Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia. J Opioid Manag 2007;3:167170.

    • Search Google Scholar
    • Export Citation
  • 50.

    Prommer E. Modafinil: is it ready for prime time? J Opioid Manag 2006;2:130136.

  • 51.

    Hawley PH, Byeon JJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med 2008;11:575581.

    • Search Google Scholar
    • Export Citation
  • 52.

    Slatkin NE. Opioid switching and rotation in primary care: implementation and clinical utility. Curr Med Res Opin 2009;25:21332150.

  • 53.

    Mercadante S, Arcuri E, Ferrera P et al. . Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage 2005;30:485491.

    • Search Google Scholar
    • Export Citation
  • 54.

    Greenberg HS, Taren J, Ensminger WD, Doan K. Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. J Neurosurg 1982;57:360364.

    • Search Google Scholar
    • Export Citation
  • 55.

    Chen H, Lamer TJ, Rho RH et al. . Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc 2004;79:15331545.

  • 56.

    Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist 2004;9:571591.

  • 57.

    Jin Y, Desta Z, Stearns V et al. . CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005;97:3039.

    • Search Google Scholar
    • Export Citation
  • 58.

    Manfredi PL, Gonzales GR, Sady R et al. . Neuropathic pain in patients with cancer. J Palliat Care 2003;19:115118.

  • 59.

    Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol 2004;22:33893394.

    • Search Google Scholar
    • Export Citation
  • Levy MH, Chwistek M, Mehta RS. Management of chronic pain in cancer survivors. Cancer J 2008;14:401409.

  • Levy MH, Samuel TA. Management of cancer pain. Semin Oncol 2005;32:179193.

  • Kochhar R, Legrand SB, Walsh D et al. . Opioids in cancer pain: common dosing errors. Oncology (Williston Park) 2003;17:571575; discussion 575–576, 579.

    • Search Google Scholar
    • Export Citation
  • Ripamonti C, Zecca E, Bruera E. An update on the clinical use of methadone for cancer pain. Pain 1997;70:109115.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 2478 606 25
PDF Downloads 674 261 24
EPUB Downloads 0 0 0